Effects of erdosteine on bleomycin-induced lung fibrosis in rats

被引:37
|
作者
Boyaci, H
Maral, H
Turan, G
Basyigit, I
Dillioglugil, MÖ
Yildiz, F
Tugay, M
Pala, A
Erçin, C
机构
[1] Kocaeli Univ, Sch Med, Dept Pediat Surg, Kocaeli, Turkey
[2] Kocaeli Univ, Sch Med, Dept Pathol, Kocaeli, Turkey
[3] Kocaeli Univ, Sch Med, Dept Biochem, Kocaeli, Turkey
[4] Kocaeli Univ, Sch Med, Dept Chest Dis, Kocaeli, Turkey
关键词
bleomycin; erdosteine; lung; nitric oxide;
D O I
10.1007/s11010-006-0640-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This study was designed to examine the effects of erdosteine on bleomycin (BLM)-induced lung fibrosis in rats. Thirty-three Sprague-Dawley rats were divided randomly into three groups, bleomycin alone (BLM), bleomycin+erdosteine (BLM+ERD), and saline alone (control). The BLM and BLM+ERD groups, were given 2.5 mg/kg BLM intratracheally. The first dose of oral erdosteine (10 mg/kg/day) in the BLM+ERD group was started 2 days before BLM administration and continued until animals were sacrificed. Animals were sacrificed 14 days after intratracheal instillation of BLM. The effect of erdosteine on pulmonary fibrosis was studied by analysis of bronchoalveolar lavage (BAL) fluid, histopathology, and biochemical measurements of lung tissue superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, malondialdehyde (MDA) as an index for lipid peroxidation, and nitrite/nitrate levels. Bleomycin-induced lung fibrosis as determined by lung histology was prevented with erdosteine (grades of fibrosis were 4.9, 2.3, and 0.2 in BLM, BLM+ERD, and control groups, respectively). Erdosteine also prevented bleomycin-induced increase in MDA (MDA levels were 0.50 +/- 0.15, 0.11 +/- 0.02, and 0.087 +/- 0.03 nmol/mg protein in BLM, BLM+ERD, and control groups, respectively) and nitrite/nitrate (nitrite/nitrate levels were 0.92 +/- 0.06, 0.60 +/- 0.09, and 0.56 +/- 0.1 mu mol/mg protein in BLM, BLM+ERD, and control groups respectively) levels. Bleomycin-induced decrease in GSH and SOD levels in the lung tissue also prevented by erdosteine [(GSH levels were 213.5 +/- 12.4, 253.2 +/- 25.2, and 287.9 +/- 34.4 nmol/mg protein) (SOD levels were 1.42 +/- 0.12, 1.75 +/- 0.17, and 1.89 +/- 0.09 U/mg protein) in BLM, BLM+ERD, and control groups respectively]. Erdosteine prevented bleomycin-induced increases in total cell number and neutrophil content of the BAL fluid. In conclusion, oral erdosteine is effective in prevention of BLM-induced lung fibrosis in rats possibly via the repression of neutrophil accumulation, inhibition of lipid peroxidation, and maintenance of antioxidant and free radical scavenger properties.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 50 条
  • [21] Ameliorative Effects of Atorvastatin on Bleomycin-Induced Pulmonary Fibrosis in Rats
    Hemmeti, Ali Asghar
    Zerafatfard, Mohammad Rahim
    Goudarzi, Mehdi
    Khodayar, Mohammad Javad
    Rezaie, Anahita
    Nooshabadi, Mohammad Reza Rashidi
    Kiani, Milad
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2016, 11 (04)
  • [22] Protective and Therapeutic Effect of Apocynin on Bleomycin-Induced Lung Fibrosis in Rats
    Kilic, Talat
    Parlakpinar, Hakan
    Taslidere, Elif
    Yildiz, Sedat
    Polat, Alaadin
    Vardi, Nigar
    Colak, Cemil
    Ermis, Hilal
    INFLAMMATION, 2015, 38 (03) : 1166 - 1180
  • [23] Protective and Therapeutic Effect of Molsidomine on Bleomycin-Induced Lung Fibrosis in Rats
    Kilic, Talat
    Parlakpinar, Hakan
    Polat, Alaadin
    Taslidere, Elif
    Vardi, Nigar
    Sarihan, Ediz
    Ermis, Hilal
    Tanbag, Kevser
    INFLAMMATION, 2014, 37 (04) : 1167 - 1178
  • [24] DEFEROXAMINE INJECTION DOES NOT AFFECT BLEOMYCIN-INDUCED LUNG FIBROSIS IN RATS
    CROSS, CE
    WARREN, D
    GERRIETS, JE
    WILSON, DW
    HALLIWELL, B
    LAST, JA
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1985, 106 (04): : 433 - 438
  • [25] Protective and Therapeutic Effect of Molsidomine on Bleomycin-Induced Lung Fibrosis in Rats
    Talat Kilic
    Hakan Parlakpinar
    Alaadin Polat
    Elif Taslidere
    Nigar Vardi
    Ediz Sarihan
    Hilal Ermis
    Kevser Tanbag
    Inflammation, 2014, 37 : 1167 - 1178
  • [26] Chronic intermittent hypoxia worsens bleomycin-induced lung fibrosis in rats
    Braun, Rudolf K.
    Broytman, Oleg
    Braun, Felix M.
    Brinkman, Jacqueline A.
    Clithero, Andrew
    Modi, Dhruvangkumar
    Pegelow, David F.
    Eldridge, Marlowe
    Teodorescu, Mihaela
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2018, 256 : 97 - 108
  • [27] Protective and Therapeutic Effect of Apocynin on Bleomycin-Induced Lung Fibrosis in Rats
    Talat Kilic
    Hakan Parlakpinar
    Elif Taslidere
    Sedat Yildiz
    Alaadin Polat
    Nigar Vardi
    Cemil Colak
    Hilal Ermis
    Inflammation, 2015, 38 : 1166 - 1180
  • [28] PROGRESS OF BLEOMYCIN-INDUCED LUNG FIBROSIS IN RABBITS
    OCONNOR, CM
    OBRIEN, A
    SWEENEY, EC
    FITZGERALD, MX
    BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, 1986, 67 (04): : 461 - 471
  • [29] EFFECTS OF GAMMA-INTERFERON ON COLLAGEN AND HISTAMINE CONTENT IN BLEOMYCIN-INDUCED LUNG FIBROSIS IN RATS
    OKADA, T
    SUGIE, I
    AISAKA, K
    LYMPHOKINE AND CYTOKINE RESEARCH, 1993, 12 (02): : 87 - 91
  • [30] Attenuation Of Bleomycin Induced Lung Fibrosis By Erdosteine And Inhibition Of The Inducible Nitric Oxide Synthase In Rats
    Guzel, A.
    Kayhan, S.
    Tutuncu, S.
    Guzel, A.
    Duran, L.
    Alacam, H.
    Gunaydin, M.
    Torun, A. Caglar
    Yilmaz, M.
    Selcuk, M. Y.
    Murat, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189